Realheart granted SEK 500,000 for blood research
The Winberg Foundation has awarded Realheart a grant of SEK 500,000 to further study how today’s heart pumps affect the blood in order to eliminate side effects in the next generation of artificial hearts. The research, led by Realheart’s CEO Ina Laura Perkins and Professor Michael Uhlin from the Karolinska Institute, is at the forefront of heart pump research and can shorten Realheart’s time to reach the market.Heart failure is one of the leading causes of death globally. Heart pumps save lives, but today’s pumps cause many blood-related, often life-threatening, side effects. An important